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Albert Szent-Györgyi’s Studies on Flavones.  
Impact of the Discovery  
 In 1936 Albert Szent-Györgyi and his colleagues published several papers on 
the influence of substances of the flavone group on the permeability of capil-
laries. The dates are also interesting. The first, 40-line article was published in 
English, signed by Rusznyák and Szent-Györgyi (27 May, 1936), the second one 
was published in German (14 August, 1936), and the third one in Hungarian 
(3 October, 1936). The latter 2 articles listed 5 authors: Armentano, Bentsáth, 
Béres, Rusznyák and Szent-Györgyi (Fig. 1–5).
Fig. 1. István Rusznyák
Fig. 2. Albert Szent-Györgyi
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Fig. 3. Vitamin  P: flavonols as vitamins (Rusznyák and Szent-Györgyi: Nature. 1938, 27 (1936). 
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Fig. 4. Deutsche Medizinische Wochenschrift (1936) (Armentano et al.)
Fig. 5. Orvosi Hetilap, 1936 (Armentano et al.).
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Armentano (1936) achieved good therapeutic results in haemorrhagic diath-
esis with the vitamin C-rich paprika preparation vitapric. However, his group 
could not reach the same results when using pure vitamin C. Therefore, they 
suggested that the aforementioned beneficial effect should not be attributed 
to vitamin C but rather to another substance, which is present in the fruit 
together with ascorbic acid (Armentano et al, 1936).
Interestingly  they used lemon instead of paprika to clarify the situation. It 
is worth mentioning that 200 kilos of lemon was processed and the resulting 
70 litres of lemon juice was enough to produce only 2 g of a pure crystalline 
substance they called c̔itrin’ (citrus flavone).
Investigati on of the therapeutic effect 
The therapeutic effect of citrin was examined in 17 patients, merely 3 of whom 
were suffering from vascular purpura and 4 from thrombocytopenic purpura. 
Since bleeding in such patients depends on unpredictable factors and acute 
thrombocytopenia can resolve spontaneously, chronic cases were examined 
to prevent flaws, and the course of the disease was followed with exact meas-
urements (number of thrombocytes, capillary resistance). For the latter meas-
urement, the method of Borbély was used, where negative pressure is exerted 
on the skin of the supraclavicular fossa until the first spot-like haemorrhage 
(petechia) develops. In addition, the Landis-Michel method was used to exam-
ine capillary permeability to plasma and proteins.
It is worth mentioning that the best results were achieved in vascular pur-
pura and the therapeutic effect of citrin was best demonstrated in the above 
mentioned 3 patients (Armentano et al. 1936) (Fig. 6).
Fig. 6. Vascular purpura
98
Miklós Gábor 
It is also interesting that the findings of a study on only 3 patients drew 
attention to research on flavonoids worldwide. I should mention that citrin 
therapy was not found to be beneficial in thrombocytopenic purpura; however, 
its ineffectiveness was not explained.  
The patients received daily intravenous flavone injections (equivalent 
to 20–40 mg of dry matter) and some days later, usually on the day 8–12, 
the effect on capillaries was checked. 75 years later, it is know that scorbu-
togenic guinea pigs were also given flavones, and they outlived the control 
subjects. It seems likely that these experiments preceded the studies on 
haemorrhagic patients, which would explain why flavone was administered 
intravenously to the human patients. 
Attentive readers may note Szent-Györgyi’s question as to whether the cap-
illary effect described in connection with citrin is a characteristic feature of 
this substance only, or the other members of the flavone group have similar 
properties. 
Informative experiments with quercitrin and rhamnetin yielded no results. 
However, Armentano et al. (1936) found it surprising that, while all the treated 
patients tolerated citrin injections well with no unpleasant side-effects, quer-
citrin and rhamnetin injections led to high fever and collapse in some cases; 
the treatment therefore had to be stopped early. 
Szent-Györgyi and his colleagues concluded that, besides vitamin C, 
there has to be another capillary-active vitamin in plants (lemon and 
paprika). They succelded is isolating a substance (citrin) from lemon 
juice, which turned out to be a f lavonoid glycoside.  This substance was 
effective in the treatment of vascular purpura, while it had no beneficial 
effect in thrombocytopenic purpura. Citrin can also inhibit protein per-
meability in diseases where the capillaries are more permeable (serous 
inf lammation). This substance was therefore called vitamin P (perme-
ability).
In his foreword to my book on the anti-inflammatory properties of fla-
vonoids, Szent-Györgyi states that he chose a letter on the far unoccupied 
side of the letters ABC’ already being used to designate vitamins in case the 
bioflavonoids were found not to be true vitamins and correction could be 
made without confusion (1972).
At the end of 1936, Albert Szent-Györgyi published a paper entitled ῾From 
Vitamin C to Vitamin P’, In which he stated that ῾If the vitamin character of 
this substance be firmly established, this will also mean that the great group 
of vegetable dyes, the flavones, which seem to play such an important role in 
plant biochemistry, also function in the animal organism.’
Albert Szent-Györgyi’s Studies on Flavones. Impact of the Discovery   
99
The chemical composition of citrin 
Szent-Györgyi chose to determine the chemical properties of citrin as his next 
task.  Fortunately, Győző Bruckner, one of the most excellent chemists and 
scientists of the 20th century, was working in his institute at that time (Fig. 7). 
According to a legend which survives to the present day, Szent-Györgyi also 
invited the world-famous professor of chemistry, Géza Zemplén from Buda-
pest to help solve the problem. The discussions and the accompanying feast 
lasted all day. It was well known that Géza Zemplén needed alcoholic stimu-
lation to set to work. In the evening, Győző Bruckner escorted Géza Zem-
plén to the railway station, then immediately returned to the laboratory and 
the same night discovered that citrin is composed of two flavone compounds: 
hesperidin and eriodictyol glycoside (Fig.s 8 and 9). In the morning Profes-
sor Zemplén was sent a telegram to inform him of the result. Bruckner and 
Szent-Györgyi published the findings of  their investigation in Nature (Fig. 10). 
The above-mentioned ῾legend’ is confirmed by a letter I received from 
Professor Bruckner (1977) (Fig. 11). 
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Fig. 10. Chemical nature of citrin  
(Bruckner and Szent-Györgyi: Nature, 1936).
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Fig. 11. Letter of Győző Bruckner (1977).
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The effect of citrin on experimentally induced scurvy 
The vitamin-like properties of flavones were widely researched by Szent-
Györgyi and his colleagues (Bentsáth et al., 1936), work which was later criti-
cized by many scientists.  Guinea pigs were kept on the Sherman, LaMer, 
Campbell vitamin C-free diet (1922). One group, the untreated controls, died 
in an average of 28.5 days. The group given one milligram of citrin daily for 6 
weeks lived an average of 44 days. All of the animals in both groups showed 
the typical symptoms of scurvy. Szent-Györgyi and his colleagues concluded 
t̔hat these results suggest that experimental scurvy, as commonly known, is 
a deficiency disease caused by the combined lack of vitamins C and P.’ 
In another experiment, Bentsáth, Rusznyák and Szent-Györgyi (1937) 
examined the vitamin P-like effects of hesperidin, demethylated hesperidin 
and quercitrin in guinea pigs. Animals that also received ascorbic acid showed 
normal growth patterns. Animals treated with hesperidin and demethylated 
hesperidin exhibited a similar response to those treated with citrin (Bentsáth 
et al., 1937). Animals that were fed a basic diet or basic diet+quercitrin died 
of severe scurvy around day 28.
Bentsáth and Das (1937) did not obtain the same results when they 
repeated their experiments. They concluded that the  winter food of 
the animals was significantly different from their summer food and that 
studied animals had to be in a good physical condition for the vitamin P 
test and they could not lack any vital factors. In their opinion, if any  vital 
factor was missing, citrin could not prolong the lifespan of the studied 
animals. 
Szent-Györgyi asked other scientists to repeat his studies. The results were 
partly corroborative and partly negative. In 1937, Szent-Györgyi and Bentsáth 
stated, ῾Vitamin P requires for its activity the presence of ascorbic acid. In 
the total absence of ascorbic acid, Vitamin P is inactive’.
Flavonoid research in the forefront of Albert Szent-Györgyi’s 
interest 
Albert Szent-Györgyi was passionate about flavonoid research, as illustrated 
by the following features: 
1. He wrote an article entitled ῾From Vitamin C to Vitamin P’.
2. He devised a method to extract greater amounts of citrin from lemon 
and published this method in Hoppe-Seylers Z. physiol. Chemie (1938).
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3. When receiving the Nobel Prize, he gave an account of his research 
into flavonoids. 
4. He developed a process to produce flavonoids and had this method 
patented in the United States in 1939 (Fig. 12).
5. At the conference on ῾Bioflavonoids and the Capillary,’ organized by 
the New York Academy of Sciences in 1955, he gave an interesting 
presentation on the perspectives of bioflavonoids.
Fig. 12. Patent of Albert Szent-Györgyi (1939).
Correspondence with Prof. Szent-Györgyi 
For several decades I had been researching the pharmacological properties 
of natural substances (plant dyes and flavonoids). By 1969, I considered that 
I had sufficient enough information to write a monograph on the anti-inflam-
matory effects of flavonoids. I had the idea to ask Professor Szent-Györgyi to 
write the foreword to this book. I attached the offprint of my publications, 
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the review of my monograph published in German by the Hungarian Acad-
emy of Sciences (Akadémiai Kiadó, Budapest) in 1960, and a photo showing 
Szent-Györgyi himself during an interview on the day of the Nobel Prize 
notification in 1937.
In his response, Szent-Györgyi expressed his delight at my intention to 
publish my book in English, arguing that everything published in a language 
other than English was ignored in the United States. He also complained of 
agitation driven by personal interests to force ῾useless and ineffective’ flavones 
out of the market (Fig. 13).
Fig. 13. First letter of professor Albert Szent-Györgyi.
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In 1970, I asked Szent-Györgyi to write the foreword to my English-language 
book, ῾The Anti-inflammatory Action of Flavonoids.’ In his response, Szent-
Györgyi thanked me for the request, adding that he only had time for a short 
one (Fig. 14).  The foreword and the accompanying letter arrived in January, 
1971 (Figs. 15, 16).
Fig. 14. The response by Professor Szent-Györgyi,  
in wich he promised to write the foreword.
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Fig. 15, 16. The letter that accompanied the foreword.
In 2008, our correspondence was published in Orvosi Hetilap, the oldest medi-
cal journal in Hungary, as requested by János Fehér, editor-in-chief. 
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Fig. 16. The anti-inflammatory action of flavonoids  
(Akadémiai Kiadó, Budapest, 1972).
Can citrin be considered a vitamin? 
Rusznyák and Benkő gave a lecture at the 10th Convention of the Hungarian 
Association of Internists {Magyar Belorvosok Egyesülete} on 28 May, 1941. 
Interestingly their lecture, ῾Is citrin a vitamin?’, was published as an offprint 
(Fig. 17).
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Fig. 17. Is citrin a vitamin? (Rusznyák and Benkő, 1941).
Guinea pigs and rats were kept on the scorbutic Sherman – La Mer – Camp-
bell deficiency diet and capillary resistance was measured on the shaved and 
depilated back of the animals with a glass cup 8 mm in internal diameter 
(Borbély method). In their guinea pig experiments they determined the mini-
mum vacuum required to produce the first spot-like haemorrhage (petechia) 
in 15 sec. In rats they applied a vacuum of 250 mm Hg and measured the time 
until the first petechia appeared. As a result of the deficiency diet, the normal 
capillary resistance of the guinea pigs dropped significantly, and this decrease 
continued in spite of the fact that they were given 3 mg of ascorbic acid daily. 
However, the capillary resistance resumed its baseline level after the ani-
mals were injected with 4 mg of subcutaneous citrin (extracted according to 
the original Szent-Györgyi method). Here I would like to present the results 
with the original figures of Rusznyák and Benkő’s article (1941) (Figs 18 and 19)
On the basis of their experiments, Rusznyák and Benkő (1941) drew the fol-
lowing conclusions: 
•  the scorbutic diet is low in both ascorbic acid and flavonoids,
•  an insufficient intake of flavonoids leads to a decrease in capillary resist-
ance, regardless of the vitamin C deficiency, but the resistance can be 
normalized by increasing the flavonoid intake,
•  experimental scurvy is double avitaminosis.
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As a result of a scorbutogenic diet, the capillary resistance of rats decreases 
significantly, often as rapidly as in 2 weeks.
Next, Rusznyák and Benkő (1941) described the course of an experiment. 
At the beginning of the experiment, the rat’s capillary resistance was low and 
it took more than 5 min to induce petechiae with a vacuum of 25 cmHg. As 
a result of the diet this value decreased to 15 sec in 4 weeks. Daily administra-
tion of 4 mg of  citrin (Richter-Budapest) increased the capillary resistance to 
the baseline level in 3 weeks (Fig. 19).
Fig. 18. Effects of citrin in guinea pigs kept on scorbutogenic diet (fig. original). 
Fig. 19. Effect of citrin on rats kept on scorbutogenic diet (fig. original).
Albert Szent-Györgyi’s Studies on Flavones. Impact of the Discovery   
111
It is worth mentioning that Rusznyák and Benkő (1941) reached similar results 
when working with various citrin preparations (Richter, Budapest; Bayer, Lev-
erkusen; Hoffmann-La Roche, Basel). These data demonstrate that citrin was pro-
duced by both Hungarian and foreign pharmaceutical companies as early as 1940.
The interest of pharmaceutical companies’ in citrin is also revealed by the fact 
that Lautenschläger and Lindner (Winthrop Chemical Company, Inc., New York) 
submitted a request in 1941 to derive purified flavanone glycosides. The process 
was patented in 1944. Patent number: 2,359,126 [14] (Fig. 20).
20. kép. Patent of Lautenschläger et al. (1944).
Recommendation to drop the name ῾vitamin P’ 
The American Society of Biological Chemists and The American Institute of 
Nutrition Committee on Nomenclature recommended dropping the name 
῾vitamin P’, arguing that there was no evidence at all that flavonoids increased 
the life expectancy of rats suffering from scurvy or fprocessed vitamin-like 
properties. The recommendation was signed by Vickery, H.B., Nelson, E.M., 




Retrospective justification of the recommendation 
From the beginning of the 1950s, we performed several series of experi-
ments on the pharmacological effects of indenochromene derivatives 
(haematoxylin, haematein, brazilin and brazilein) (Fig. 21). Similarly to 
Rusznyák and Benkő (1941) we examined the effect of haematoxylin on 
capillary resistance in rats the kept on a scorbutogenic diet (Gábor and 
Dux, 1952). As a result of the diet, capillary resistance stagnated at a low 
level for several weeks and petechiae appeared following a vacuum of sec-
onds (Fig. 22, curve C).
Fig. 21. Haematoxyline and haemateine
Rats weighing 190–210 g received a subcutaneous (occipital region) injection 
of 15 mg of haematoxylin every third day. Only 2 weeks following the onset of 
the therapy it took more than 5 minutes to induce petechiae. Measurements 
performed 12 days after the completion of the therapy showed minimum 
capillary resistance (Fig. 22, curve A). Haematein therapy yielded similar 
results (Fig. 22, curve B).
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Fig. 22. Effects of haematoxylin and haematein on rats kept on scorbutogenic diet  
(fig. original, Gábor and Dux, 1952).
Our experiments confirmed that the resistance-increasing effect of a drug 
(̔ pharmacon’) does not justify its vitamin-like properties, and it therefore 
cannot be named a vitamin.
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The first conference on bioflavonoids 
The conference on ῾Bioflavonoids and the capillary’ was organized by 
the New York Academy of Sciences and held on 11 February, 1955. As 
revealed by the programme of the symposium, the term ῾Vitamin P’ was 
no longer used. 
We should also note that Albert Szent-Györgyi gave a presentation entitled 
῾Perspectives for the Bioflavonoids’ at the conference. 
Fig. 23. Bioflavonoids and the capillary (Conference in New York, 1955).
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The mechanism of action of flavonoids 
Exploration of the mechanism of  action of flavonoids is an  important field. 
In connection with this, it is worth citing Szent-Györgyi’s presentation 
(1955): A̔s a chemist, I am deeply impressed by the reaction of flavonoids 
with metals, while as a biochemist, I am increasingly impressed by the cen-
tral role metal atoms play in biological function. So it seems possible that 
the reactions of flavones with metals hold the key to the understanding of 
their biological function, while the flavonoid metal complexes may hold 
the key to a better understanding of the working of the machinery of life.’ 
(Szent-Györgyi, 1955). To illustrate his ideas for the sake of better under-
standing, I would like to introduce the formation of quercetin-copper chelate 
complexes, published by Clark and Geissman (1949). 3’,4’-Dihydroxy and 
3-hydroxy-4-keto groups are important constituents of flavonoid compounds 
(Fig. 24).
Fig. 24. Structure of quercetine-copper chelate complexes.
Modern ideas concerning the mode of action of flavonoids are illustrated with 
a figure taken from the paper of Kim et al. (2004) (Fig. 25).
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Fig. 25. Mechanism of action of flavonoids (Kim et al., 2004).
Phenylbenzopyrone, chromone and chromane derivatives in 
medications 
Threeimportant chemical formulae may be given (Fig. 26).
Fig. 26. Structural formulae of pyrone, chromone and 2-phenylbenzo-γ-pyrone (flavone).
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Nowadays there is no doubt that it was the result of Szent-Györgyi’s research 
that focused attention on the study of phenylbenzopyrones (flavones) and 
related derivatives.
The research into phenylbenzopyrone, chromone and chromane deriva-
tives is of outstanding importance; it has already led to the discovery of a 
number of medications with various pharmacological effects. I have described 
the pharmacology of these derivatives and other related compounds in my 
books (Gábor, 1986, 1988) (Fig. 27).
Fig. 27. The Pharmacology of Benzopyrone derivatives and Related Compounds  
(Gábor, 1986).
It is worth mentioning the monograph by Casley-Smith and Judith Casley-
Smith, published in Australia in the same year: High-protein oedemas and 
the benzo-pyrones' (1986) (Fig. 28).
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The pharmacological study of benzopyrones led to the discovery of new 
medications, many of which are available on the market. I would like to men-
tion some which are used in medical treatment.
Flavone-containing medications marketed in Hungary 
Rutascorbin
Rutascorbin is one of the flavonoid drugs with the longest history. It is used 
in the treatment of a chronic venous insufficiency and haemorrhoids. In oph-
thalmology, the range of application includes subconjunctival haemorrhage 
and diabetic retinopathy. 
Detralex
The active substance is a purified and micronized flavonoid fraction, which 
contains diosmin and other flavonoids expressed as hesperidin. It is recom-
mended for the treatment of chronic venous insufficiency of the lower limb 
and haemorrhoids. In some countries a micronized purified flavonoid frac-
tion containing 450 mg of diosmin and 50 mg of hesperidin is also marketed 
under the name Daflon 500 mg. 
Venoruton
This has been used for decades in the treatment of venous insufficiency, 
venous circulatory disorders, leg ulceration, haemorrhoids and diabetic retin-
opathy. Composition: 0-(β-hydroxyethyl) rutosides (oxerutin).
Medications containing benzopyr one or its derivatives on foreign markets 
Earlier gave a detailed description of the pharmacology of benzopyr one deriv-
atives and some related compounds (Gábor, 1986). (For the sake of brevity, I 
reform here to this monograph.) I mention merly ormeloxifene, the selective 
oestrogen receptor modulator, which is interesting from a pharmacological 
aspect. 
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Fig. 28. High protein oedemas and the benzo-pyrones  
(J. R. Casley-Smith and J Casley-Smith, 1986).
Ormeloxifene (Centchroman)
It is 3,4-trans-2,2-dimethyl-3-phenyl-4-(p-(β-pyrrolidinoethoxy)-phenyl)-7-
methoxychroman. Its anti-inflammatory effect was first reported by Dhawan 
and Srimal in 1973. It is worth mentioning that in India it has been avail-
able since the beginning of the 1990s as a contraceptive under various names 
(Saheli, Novex; Hindustan Latex Ltd). For the treatment of dysfunctional 
haemorrhages, it is marketed under the name Sevista by Torrent Pharma-
ceuticals. 
As a contraceptive, ormeloxifene is recommended to be taken orally, once 
a week (Twice a week in the first 12 weeks). Its contraceptive use was legalized 
in India in 2009. 
120
Miklós Gábor 
Flavonoid-containing herbal combinations used as drugs 
Scutellaria species are widespread in nature (S. lateriflora, S. hastifolia, 
S. altissima and S. baicalensis). In the last decade, S. baicalensis was used in 
the development of 2 medications.
SK Ato formula
Lim et al. (2006) reported a topical anti-inflammatory flavonoid preparation, SK Ato 
Formula. The preparation contains flavonoid mixtures from Scutellaria baicalensis, 
Georgi roots and Ginkgo biloba L. leaves with an extract of Gentiana scabra. 
Several flavonoid compounds have been isolated from Scutellaria baicalen-
sis (baicalin, wogonin, oroxylin A, etc.). The leaves of Ginkgo biloba contain 
myricetin, quercetin, and the biflavone, ginkgetin among other.
Flavocoxid (Limbrel®)
Burnett et al. (2007) analysed the cyclooxygenase-1, 2 and 5-lipoxygenase 
inhibitor effect of the mixed extract of Scutellaria baicalensis and Acacia 
catechu (baicalin and catechin). The mixed extract (flavocoxide) is used in 
the treatment of inflammatory knee diseases (osteoarthritis).
Bioflavonoid conferences, international polyphenol associations 
As I mentioned earlier, the first conference on bioflavonoids was organized by 
the New York Academy of Sciences in 1955. I am glad to report that the Hun-
garian Academy of Sciences founded the Committee for Flavonoid research in 
1964 to coordinate and publish the findings of Hungarian flavone research. It 
was at one of the first sessions that we decided to replace the term ῾vitamin P’ 
with ῾bioflavonoids’ when referring to biologically active flavone compounds. 
This terminology has not changed in the past 4 decades.
The following institutions have contributed most to the work of the Com-
mittee: Budapest University of Technology and Economics, Department of 
Organic Chemistry at the University of Debrecen, and the Department of 
Microbiology, the Institute of Pharmacognosy and the Department of Phar-
maceutical Technology at the University of Szeged. 
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The first president of the Committee for Flavonoid research was Acad-
emician Rezső Bognár. Later the Committee was presided by Academicians 
Loránd Farkas and Sándor Antus.
The first and second symposia (1965 and 1967) were held in Szeged, while 
the next one was hosted by Debrecen (1970). Since then, the national symposia 
have been held every year and the international ones every four-to-five years. 
The lectures presented at the international symposia are published in English 
by the Hungarian Academy of Sciences.
I may note that the 6th Hungarian Bioflavonoid symposium was held in 
Munich (1977), the 7th in Szeged (1985) Fig. 30, and the 9th in Vienna (1995). 
Fig. 29. Ormeloxifene
In 2012 the Committee received new tasks under the new name ‘Committee 
on Alkaloid and Flavonoid Chemistry’. Its sessions are held every year fol-
lowing in the footsteps of Hungarian flavonoid research.
I would like to mention the Venoruton symposia (in the German literature: 
O-(β-hydroxyethyl) rutoside) where experimental and clinical results were pre-
sented. (Nyon, 1972, Mayschoss, 1978, Ludwigsburg, 1982, and Darmstadt, 1990). 
The presentations were also published by Springer Verlag and Medikon Verlag.
The Groupe Polyphénols (GP) society is an international association 
founded in France in 1972 with the aim of promoting research on plant 
polyphenols. Its head office is in Bordeaux and its conferences (International 
Conference on Polyphenols, ICP) are held every 2 years. 
The research on polyphenols is still at the focus of attention, as indicated 
by the 7th World Congress of the International Society of Antioxidants in 
Nutrition and Health, entitled Polyphenols Applications, held in Bonn in 2013. 
(Fig. 31). These congresses have been organized yearly since 2004. 
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Fig. 30. The 7th Hungarian Bioflavonoid Symposium (Szeged, 1985). 
I conclusion, we can say that the intensity of flavone (polyphenol) research is 
still unbroken, following in the path of Szent-Györgyi and his colleagues. It 
gives me special joy to see that Hungarian scientists continue to play a signifi-
cant role in this research. I think it is most appropriate to finish my presenta-
tion with a quotation from the Nobel-laureate Albert Szent-Györgyi (1955): 
῾I hope to leave the reader with the impression that flavonoids comprise one 
of the most exciting, broad, and hopeful fields of biological inquiry, and I am 
glad to close on such an optimistic note.’ (Szent-Györgyi, 1955).
Fig. 31. International Society of Antioxidants in Nutrition and Health,  
Polyphenols Applications, 7. World Congress (Bonn, 2013).
